BMC Cancer

{{Primary sources|date=March 2025}}

{{Infobox journal

| cover =

| discipline = Oncology

| abbreviation = BMC Cancer

| website = http://www.biomedcentral.com/bmccancer

| publisher = BioMed Central

| country =

| history = 2001–present

| ISSN = 1471-2407

| impact = 3.4

| impact-year = 2023

| CODEN = BCMACL

| LCCN = 2002243079

| OCLC = 45893944

}}

BMC Cancer is a peer-reviewed open access medical journal that publishes original research on cancer and oncology. It was established in 2001 at a time when open access publishing was in its infancy, and is published by BioMed Central. It was one of the first journals to be open access and exclusively published online. {{Cite journal |last1=Chap |first1=Christna |last2=Patel |first2=Jigisha |date=2011-11-30 |title=A decade of progress in cancer research |journal=BMC Cancer |volume=11 |issue=1 |pages=498 |doi=10.1186/1471-2407-11-498 |issn=1471-2407 |pmc=3276491 |pmid=22128753 |doi-access=free }}

Abstracting and indexing

The journal is abstracted and indexed by PubMed, MEDLINE, CAS, EMBASE, Scopus, Current Contents, and CABI.{{cite web|title=Aims and scope|publisher=BioMed Central|url=https://bmccancer.biomedcentral.com/about|accessdate=16 October 2020}} According to the Journal Citation Reports, its 2-year impact factor was 3.4 in 2023.{{cite web|title=About|publisher=BioMed Central|url=https://bmccancer.biomedcentral.com/about|accessdate=2 April 2022}}

References

{{Reflist}}